Lawn, S. D. & Zumla, A. I. Tuberculosis. Lancet 378 (9785), 57–72. (2011).
WHO G. Global tuberculosis report 2020. Glob. Tuberc. Rep. (2020).
Organization, W. H. Global Tuberculosis Report 2021: Supplementary Material (World Health Organization, 2022).
Gurumurthy, P. et al. Decreased bioavailability of Rifampin and other antituberculosis drugs in patients with advanced human immunodeficiency virus disease. Antimicrob. Agents Chemother. 48 (11), 4473–4475 (2004).
McIlleron, H., Meintjes, G., Burman, W. J. & Maartens, G. Complications of antiretroviral therapy in patients with tuberculosis: drug interactions, toxicity, and immune reconstitution inflammatory syndrome. J. Infect. Dis. 196 (1), S63–75 (2007).
Organization, W. H. Consolidated Guidelines on HIV Prevention, Diagnosis, Treatment and Care for Key Populations (World Health Organization, 2016).
Tadokera, R. et al. Hypercytokinaemia accompanies HIV–tuberculosis immune reconstitution inflammatory syndrome. Eur. Respir. J. 37 (5), 1248–1259 (2011).
Mills, E. J. et al. Adherence to antiretroviral therapy in sub-Saharan Africa and North america: a meta-analysis. Jama 296 (6), 679–690 (2006).
Harries, A. D., Zachariah, R. & Lawn, S. D. Providing HIV care for co-infected tuberculosis patients: a perspective from sub-Saharan Africa. Int. J. Tuberc Lung Dis. 13 (1), 6–16 (2009).
CDC. Managing drug interactions in the treatment of HIV-related tuberculosis. http://www.cdc.gov/tb/TB_HIV_Drugs/default.htm (2013).
MoH Ethiopia. Guidelines for Clinical and Programmatic Management of TB, TB/HIV, DR-TB and Leprosy in Ethiopia 2021.
Arnesen, R., Moll, A. P. & Shenoi, S. V. Predictors of lost to follow-up among patients on ART at a rural hospital in KwaZulu-Natal, South Africa. PLoS One. 12 (5), e0177168 (2017).
Haas, A. D. et al. Retention and mortality on antiretroviral therapy in sub-Saharan africa: collaborative analyses of HIV treatment programmes. J. Int. AIDS. Soc. 21 (2), e25084 (2018).
Joseph Davey, D. et al. Same-day antiretroviral therapy is associated with increased lost to follow‐up in South African public health facilities: a prospective cohort study of patients diagnosed with HIV. J. Int. AIDS. Soc. 23 (6), e25529 (2020).
Khumalo, P. G., Chou, Y. J. & Pu, C. Antiretroviral treatment attrition in swaziland: a population-based study. Epidemiol. Infect. 144 (16), 3474–3482 (2016).
Legesse, T. et al. Trends of tuberculosis treatment outcomes of notified cases in three refugee camps in sudan: a four-year retrospective analysis, 2014–2017. Sudan. J. Med. Sci. 16 (2), 259–275 (2021).
Mugisha, V. et al. Determinants of mortality and lost to follow-up among adults enrolled in HIV care services in Rwanda. PLoS One. 9 (1), e85774 (2014).
Nacarapa, E. et al. Predictors of attrition among adults in a rural HIV clinic in Southern mozambique: 18-year retrospective study. Sci. Rep. 11 (1), 17897 (2021).
Nansera, D. et al. Mortality and lost to follow-up among tuberculosis and HIV co-infected patients in rural Southwestern Uganda. Int. J. Tuberc. Lung Dis. 16 (10), 1371–1376 (2012).
Ntabanganyimana, D., Rugema, L., Omolo, J., Nsekuye, O. & Malamba, S. S. Incidence and factors associated with being lost to follow-up among people living with HIV and receiving antiretroviral therapy in nyarugenge the central business district of Kigali city, Rwanda. PLoS One. 17 (10), e0275954 (2022).
Wekesa, P., McLigeyo, A., Owuor, K., Mwangi, J. & Ngugi, E. Survival probability and factors associated with time to lost to follow-up and mortality among patients on antiretroviral treatment in central Kenya. BMC Infect. Dis. 22 (1), 522 (2022).
Zürcher, K. et al. Outcomes of HIV-positive patients lost to follow‐up in African treatment programmes. Tropical Med. Int. Health. 22 (4), 375–387 (2017).
Carriquiry, G. et al. Mortality and lost to follow-up among HIV-infected persons on long-term antiretroviral therapy in Latin America and the Caribbean. J. Int. AIDS Soc. 18 (1), 20016 (2015).
Dessu, S., Mesele, M., Habte, A. & Dawit, Z. Time until lost to follow-up, incidence, and predictors among adults taking ART at public hospitals in Southern Ethiopia. HIV/AIDS-Res. Palliative Care 205 – 215. (2021).
Gezae, K. E., Abebe, H. T. & Gebretsadik, L. G. Incidence and predictors of LTFU among adults with TB/HIV co-infection in two governmental hospitals, mekelle, ethiopia, 2009–2016: survival model approach. BMC Infect. Dis. 19 (1), 107 (2019).
Mekonnen, N., Abdulkadir, M., Shumetie, E., Baraki, A. G. & Yenit, M. K. Incidence and predictors of lost to follow-up among HIV infected adults after initiation of first line anti-retroviral therapy at university of Gondar comprehensive specialized hospital Northwest ethiopia, 2018: retrospective follow up study. BMC Res. Notes. 12 (1), 111 (2019).
Teshale, A. B., Tsegaye, A. T. & Wolde, H. F. Incidence and predictors of lost to follow up among adult HIV patients on antiretroviral therapy in university of Gondar comprehensive specialized hospital: A competing risk regression modeling. PLoS One. 15 (1), e0227473 (2020).
Tola, H. H., Azar, T., Shojaeizadeh, D. & Garmaroudi, G. Tuberculosis treatment non-adherence and lost to follow up among TB patients with or without HIV in developing countries: a systematic review. Iran. J. Public. Health. 44 (1), 1 (2015).
Kibuule, D. et al. Predictors of lost to follow-up of tuberculosis cases under the DOTS programme in Namibia. ERJ Open. Res. 6 (1). (2020).
Mekonnen, H. S. & Azagew, A. W. Non-adherence to anti-tuberculosis treatment, reasons and associated factors among TB patients attending at Gondar town health centers, Northwest Ethiopia. BMC Res. Notes. 11 (1), 691 (2018).
Shroufi, A. et al. Risk of death among those awaiting treatment for HIV infection in zimbabwe: adolescents are at particular risk. J. Int. AIDS Soc. 18 (1), 19247 (2015).
Oni, T. et al. High prevalence of subclinical tuberculosis in HIV-1-infected persons without advanced immunodeficiency: implications for TB screening. Thorax 66 (8), 669–673 (2011).
Balcha, T. T. & Jeppsson, A. Outcomes of antiretroviral treatment: a comparison between hospitals and health centers in Ethiopia. J. Int. Assoc. Physicians AIDS Care (Chic). 9 (5), 318–324 (2010).
Muñoz-Sellart, M., Cuevas, L., Tumato, M., Merid, Y. & Yassin, M. Factors associated with poor tuberculosis treatment outcome in the Southern region of Ethiopia. Int. J. Tuberc. Lung Dis. 14 (8), 973–979 (2010).
Uyei, J., Coetzee, D., Macinko, J. & Guttmacher, S. Integrated delivery of HIV and tuberculosis services in sub-Saharan africa: a systematic review. Lancet. Infect. Dis. 11 (11), 855–867 (2011).
Fine, J. P. & Gray, R. J. A proportional hazards model for the subdistribution of a competing risk. J. Am. Stat. Assoc. 94 (446), 496–509 (1999).
Gooley, T. A., Leisenring, W., Crowley, J. & Storer, B. E. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Stat. Med. 18 (6), 695–706 (1999).
Putter, H., Fiocco, M. & Geskus, R. B. Tutorial in biostatistics: competing risks and multi-state models. Stat. Med. 26 (11), 2389–2430 (2007).
Bahirdar city health Department. population projection, accounting censuses of 2007 by Ethiopian Statistical Agency (ESA), of Bahirdar city health Department. (2022).
Ministry of Health Ethiopia. Guidelines for management of Tb, Dr-Tb and leprosy in ethiopia. 6 (2017).
WHO Guidelines Approved by the Guidelines Review Committee. Consolidated Guidelines on the Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: Recommendations for a Public Health Approach. Geneva: World Health Organization Copyright © World Health Organization (2016).
Ryan, T. P. Sample Size Determination and Power (Wiley, 2013).
Epidata manager. http://www.epidata.dk (2024).
Stata version 14. https://www.stata.com/stata14/
Cran RStudio.
Zhang, Z. et al. Overview of model validation for survival regression model with competing risks using melanoma study data. Ann. Transl Med. 6 (16), 325 (2018).
Haller, B., Schmidt, G. & Ulm, K. Applying competing risks regression models: an overview. Lifetime Data Anal. 19 (1), 33–58 (2013).
Bakoyannis, G. & Touloumi, G. Practical methods for competing risks data: a review. Stat. Methods Med. Res. 21 (3), 257–272 (2012).
Matsena Zingoni, Z., Chirwa, T., Todd, J. & Musenge, E. Competing risk of mortality on lost to follow-up outcome among patients with HIV on ART: a retrospective cohort study from the Zimbabwe National ART programme. BMJ Open. 10 (10), e036136 (2020).
Kiwanuka, J., Mukulu Waila, J., Muhindo Kahungu, M., Kitonsa, J. & Kiwanuka, N. Determinants of lost to follow-up among HIV positive patients receiving antiretroviral therapy in a test and treat setting: A retrospective cohort study in masaka, Uganda. PLoS One. 15 (4), e0217606 (2020).
Shaweno, T., Getnet, M. & Fikru, C. Does time to lost to follow-up differ among adult tuberculosis patients initiated on tuberculosis treatment and care between general hospital and health centers? A retrospective cohort study. Trop. Med. Health. 48 (1), 1–11 (2020).
Kassa, G. M., Teferra, A. S., Wolde, H. F., Muluneh, A. G. & Merid, M. W. Incidence and predictors of lost to follow-up among drug-resistant tuberculosis patients at university of Gondar comprehensive specialized hospital, Northwest ethiopia: a retrospective follow-up study. BMC Infect. Dis. 19 (1), 817 (2019).
Kebede, H. K., Mwanri, L., Ward, P. & Gesesew, H. A. Predictors of lost to follow up from antiretroviral therapy among adults in sub-Saharan africa: a systematic review and meta-analysis. Infect. Dis. Poverty. 10 (1), 33 (2021).
Megerso, A. et al. Predictors of lost to follow-up in antiretroviral treatment for adult patients in the oromia region, Ethiopia. HIV AIDS (Auckl). 8, 83–92 (2016).
Birhanu, M. Y. et al. Incidence and predictors of lost to follow-up among HIV-positive adults in Northwest ethiopia: a retrospective cohort study. Trop. Med. Health. 48, 78 (2020).
Alebel, A., Sibbritt, D., Petrucka, P. & Demant, D. Undernutrition increased the risk of lost to follow-up among adults living with HIV on ART in Northwest ethiopia: a retrospective cohort study. Sci. Rep. 12 (1), 22556 (2022).
Tesha, E-D., Kishimba, R., Njau, P., Revocutus, B. & Mmbaga, E. Predictors of lost to follow up from antiretroviral therapy among adolescents with HIV/AIDS in Tanzania. PloS One. 17 (7), e0268825 (2022).
Berheto, T. M., Haile, D. B. & Mohammed, S. Predictors of lost to follow-up in patients living with HIV/AIDS after initiation of antiretroviral therapy. N Am. J. Med. Sci. 6 (9), 453–459 (2014).
Fisiha Kassa, S., Zemene Worku, W., Atalell, K. A. & Agegnehu, C. D. Incidence of lost to Follow-Up and its predictors among children with HIV on antiretroviral therapy at the university of Gondar comprehensive specialized referral hospital: A retrospective data analysis. HIV AIDS (Auckl). 12, 525–533 (2020).
Fentie, D. T., Kassa, G. M., Tiruneh, S. A. & Muche, A. A. Development and validation of a risk prediction model for lost to follow-up among adults on active antiretroviral therapy in ethiopia: a retrospective follow-up study. BMC Infect. Dis. 22 (1), 727 (2022).
Hibstie, Y. T. et al. Nearly one in every six HIV-infected children lost from ART follow-up at Debre Markos referral hospital, Northwest ethiopia: A 14-year retrospective follow-up study. PLoS One. 15 (9), e0239013 (2020).
Ogyiri, L. et al. Effect of HIV infection on TB treatment outcomes and time to mortality in two urban hospitals in Ghana-a retrospective cohort study. Pan Afr. Med. J. 32 (1). (2019).
Alebel, A., Demant, D., Petrucka, P. & Sibbritt, D. Effects of undernutrition on opportunistic infections among adults living with HIV on ART in Northwest ethiopia: using inverse-probability weighting. PLoS One. 17 (3), e0264843 (2022).
Mushy, S. E. et al. Predictors of the observed high prevalence of lost to follow-up in ART-experienced adult PLHIV: a retrospective longitudinal cohort study in the Tanga region, Tanzania. BMC Infect. Dis. 23 (1), 92 (2023).
Núñez, I. et al. Late-onset opportunistic infections while receiving anti-retroviral therapy in Latin america: burden and risk factors. Int. J. Infect. Dis. 122, 469–475 (2022).
Birhane, M., Mekonnen, S., Dingeta, T. & Teklemariam, Z. Lost to follow-up tuberculosis treatment and associated factors among adults attending at public health facilities in warder district, Somali regional state, Eastern Ethiopia. Front. Public. Health. 11, 1151077 (2023).
Walker, I. F. et al. Analysis of lost to follow-up in 4099 multidrug-resistant pulmonary tuberculosis patients. Eur. Respir. J. 54 (1). (2019).
Joung, I. M., van der Meer, J. B. & Mackenbach, J. P. Marital status and health care utilization. Int. J. Epidemiol. 24 (3), 569–575 (1995).
Mengesha, M. M., Gebremichael, M. A., Watumo, D., Hallström, I. K. & Jerene, D. Poor adult tuberculosis treatment outcome and associated factors in Gibe woreda, Southern ethiopia: an institution-based cross-sectional study. PLOS Glob Public. Health. 2 (3), e0000161 (2022).
Mishra, P. et al. Reasons for lost to follow-up (LTFU) of pulmonary TB (PTB) patients: A qualitative study among saharia, a particularly vulnerable tribal group of Madhya pradesh, India. PLoS One. 16 (12), e0261152 (2021).
Soedarsono, S. et al. Determinant factors for lost to follow-up in drug-resistant tuberculosis patients: the importance of psycho-social and economic aspects. BMC Pulm Med. 21 (1), 360 (2021).
Gashu, K. D., Gelaye, K. A. & Tilahun, B. Adherence to TB treatment remains low during continuation phase among adult patients in Northwest Ethiopia. BMC Infect. Dis. 21 (1), 1–10 (2021).
Adamashvili, N. et al. Low BMI increases all-cause mortality rates in patients with drug-resistant TB. Int. J. Tuberc Lung Dis. 26 (4), 326–333 (2022).
Aibana, O. et al. Nutritional status and tuberculosis risk in adult and pediatric household contacts. PLoS One. 11 (11), e0166333 (2016).
Jiang, Y. et al. Factors associated with lost to follow-up before and after treatment initiation among patients with tuberculosis: A 5-year observation in China. Front. Med. (Lausanne). 10, 1136094 (2023).
Lai, H. H., Lai, Y. J. & Yen, Y. F. Association of body mass index with timing of death during tuberculosis treatment. PLoS One. 12 (1), e0170104 (2017).
Wondimu, W., Dube, L. & Kabeta, T. Factors affecting survival rates among adult TB/HIV Co-Infected patients in Mizan Tepi university teaching hospital, South West Ethiopia. HIV AIDS (Auckl). 12, 157–164 (2020).
Michael, O. S., Sogaolu, O. M., Fehintola, F. A., Ige, O. M. & Falade, C. O. Adverse events to first line anti-tuberculosis drugs in patients co-infected with HIV and tuberculosis. Ann. IB. Postgrad. Med. 14 (1), 21–29 (2016).
Sant Anna, F. M. et al. Impact of adverse drug reactions on the outcomes of tuberculosis treatment. PLoS One. 18 (2), e0269765 (2023).
Manosuthi, W., Wiboonchutikul, S. & Sungkanuparph, S. Integrated therapy for HIV and tuberculosis. AIDS Res. Ther. 13, 22 (2016).
